Vol. 5 (01) pp. 3010-3015 DOI: 10.21474/IJAR01/3104

METFORMIN AND ITS SIDE EFFECTS.

, , , and
  • King Abdullah st., Riyadh City, Kingdom of Saudi Arabia, Al Imam Muhammed bin Saud Islamic University, College of Medicine, Student.
  • Alwaseet St., Riyadh City, KSA Al Imam Muhammed bin Saud Islamic University, College of Medicine, Student.
  • King Fahad St., Riyadh City, KSA, Imam University, College of Medicine, Internship.
  • Prince Muteb St., Riyadh City, KSA, Imam University, College of Medicine, student.
  • King fahad St., Riyadh City, KSA, Nephrology service resident, King Saud Medical City.
30 Downloads 202 Views
Crossref

Download Full Paper (PDF)

Abstract

Metformin and its Side Effects:- Objective: This research aims at investigating the effects of using metformin among Saudi patients in Riyadh. Methodology: (67) males and (57) females have been selected randomly to participate in this research. Self-reported questionnaire has been given to participants. Continuous variables were expressed as mean ? standard deviation and categorical variables were expressed as percentages. The t-test was used for continuous variables and chi square test was used for categorical variables. A p-value <0.05 was considered statistically significant. Results: many patients reported diarrhea and nausea as the main side effects of using this medication. However, 50% of participants have no complain. This project found no significant difference between two genders except age &using metformin. Conclusion: metformin has been used widely among Saudi patients suffering from type 2 DM. Many patients complain from side effect of this medication.

Keywords

How to Cite This Article

Sulaiman Saleh Alaqil, Moneef Mansour Aldosari, Abdulelah Sulaiman Almaiman, Hesham Abdullah Almuaili and Khwlah Mohammed Alreshaid. (2017); METFORMIN AND ITS SIDE EFFECTS., International Journal of Advanced Research (IJAR), 5 (01), 3010-3015, ISSN 2320-5407. DOI: https://doi.org/10.21474/IJAR01/3104

Corresponding Author

Sulaiman Saleh Alaqil
King Abdullah st., Riyadh City, Kingdom of Saudi Arabia

Article Analytics

References

  1. Kirpichnikov D, McFarlane SI and Sowers JR. (2002) ?American college of physicians,'?Annals of Internal Medicine. 137(1):25?33.
  2. com. (2016)."Metformin hydrochloride". Available from https://www.drugs.com/monograph/metformin-hydrochloride.html .
  3. Evans JMM, Donnelly LA, Emslie-Smith AM, Alessi DR and Morris AD (2005) ?Metformin and reduced risk of cancer in diabetic patients?BMJ. 330:7503.
  4. Chong C andChabner B. (2009) ?Mysterious metformin?,?The oncologist. 14(12):1178?81.
  5. com (2000).?"Metformin: Uses, dosage, side effects". Available from: https://www.drugs.com/metformin.html.
  6. com. (2005). "Facts and Comparisons". Available from https://www.drugs.com/ppa/
  7. Scheen AJ, Paquot N. (2013) "Metformin revisited: a critical review of the benefit-risk balance in at-risk patients with type 2 diabetes". Diabetes Metab. 39(3):179-90.
  8. Stang M, Wysowski DK and Butler-Jones D. (1999) "Incidence of lactic acidosis in metformin users",?Diabetes Care. 22(6): 925?927.
  9. Salpeter SR, Greyber E, Pasternak GA and Salpeter EE. (2003) "Risk of Fatal and Nonfatal Lactic Acidosis with Metformin use in type 2 diabetes Mellitus" Archives of Internal Medicine. 163(21):2594?2602. doi: 10.1001/archinte.163.21.2594.
  10. Kirpichnikov D, McFarlane S and Sowers J. (2002) ?Metformin: An update?Annals of internal medicine.137(1):25?33.
  11. Williams L and Wilkins: "Pathophysiology", A Wolters Kluwer Company, Philadelphia, 2005.
  12. (2016). Metformin. Available from https://medlineplus.gov/druginfo/meds/a696005.html
  13. Forrester M. (2008) "Adult metformin ingestions reported to Texas poison control centers, 2000?2006",?Hum ExpToxicol. 27(7):575?583. doi: 10.1177/0960327108090589.
  14. Gjedde S, Christiansen A, Pedersen SB and Rungby J. (2003) "Survival following a Metformin overdose of 63 g: A case report",?Pharmacology & Toxicology. 93(2):98?99. doi: 10.1034/j.1600-0773.2003.930207.x.
  15. Jones GC, Macklin JP and Alexander WD. (2003) "Contraindications to the use of metformin", Editorial. 326(7379):4?5. doi: 10.1136/bmj.326.7379.4.\
  16. Bristol-Myers Squibb Company. (no date). "GLUCOPHAGE?" Available at: http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/020357s031,021202s016lbl.pdf (Accessed: 11 November 2016).

Similar Articles

Creative Commons Attribution 4.0 This work is licensed under a Creative Commons Attribution 4.0 International License.